[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Article Types

Countries / Regions

Search Results (3)

Search Parameters:
Journal = Reports
Section = Endocrinology/Metabolism

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
7 pages, 5038 KiB  
Case Report
Pseudo-Hyperaldosteronism Arising from Licorice Cough Syrup Self-Ingestion: A Case Report
by Chien-Chun Liao and Kun-Te Lin
Reports 2024, 7(4), 85; https://doi.org/10.3390/reports7040085 - 14 Oct 2024
Viewed by 640
Abstract
Background and Clinical Significance: Licorice (glycyrrhiza glabra) cough syrup intoxication is manifested with refractory hypokalemia, hypertension, and metabolic alkalosis. The transformation of glycyrrhiza glabra metabolic into glycyrrhetic acid after ingestion further inhibits the 11-β-hydroxysteroid dehydrogenase-2 enzyme, impeding the conversion of cortisol into [...] Read more.
Background and Clinical Significance: Licorice (glycyrrhiza glabra) cough syrup intoxication is manifested with refractory hypokalemia, hypertension, and metabolic alkalosis. The transformation of glycyrrhiza glabra metabolic into glycyrrhetic acid after ingestion further inhibits the 11-β-hydroxysteroid dehydrogenase-2 enzyme, impeding the conversion of cortisol into cortisone. The accumulation of cortisol can also stimulate mineralocorticoid receptors, which leads to a pseudo-hyperaldosteronism-like effect. Case Presentation: We report a 60-year-old male patient with licorice intoxication due to the chronic consumption of licorice cough syrup. He exhibited a transient seizure lasting approximately one minute. Initially, hypokalemia (potassium level was 2.0 mmol/L), metabolic alkalosis, and QT interval prolongation with premature ventricular complexes were demonstrated on his electrocardiogram. Despite the administration of both intravenous and oral potassium supplements over two days, there was no significant improvement in hypokalemia. Spironolactone, an aldosterone receptor antagonist, was administered in addition to ongoing potassium supplementation from the 3rd day. This intervention led to a rapid normalization of hypokalemia in one day. The patient was ultimately discharged on the 6th day without any subsequent complications. Conclusions: The licorice-induced chronic intoxication, which led to pseudo-hyperaldosteronism and refractory hypokalemia, was successfully managed with aggressive potassium supplementation and spironolactone treatment. Full article
(This article belongs to the Section Endocrinology/Metabolism)
Show Figures

Figure 1

Figure 1
<p>Initially electrocardiography in the emergency department showed QTc prolongation.</p>
Full article ">Figure 2
<p>Chest X-ray in the emergency department showed unremarkable findings.</p>
Full article ">Figure 3
<p>Time to serum potassium level with spironolactone treatment highlighted.</p>
Full article ">Figure 4
<p>Electrocardiography showed no QTc prolongation after the correction of hypokalemia.</p>
Full article ">
10 pages, 414 KiB  
Article
Association between Thyroid Profile Levels and Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study
by Yu-Shan Hsieh, Ting-Teng Yang, Chung-Huei Hsu and Yan-Yu Lin
Reports 2024, 7(3), 78; https://doi.org/10.3390/reports7030078 - 16 Sep 2024
Viewed by 1116
Abstract
Background: Thyroid cancer is the most common endocrine carcinoma, accounting for 3.26% of all cancers. The most histologically, well-differentiated thyroid cancer is papillary thyroid carcinoma (PTC). Although PTC is regarded as an indolent tumor, a portion of the cancer cells metastasize to lymph [...] Read more.
Background: Thyroid cancer is the most common endocrine carcinoma, accounting for 3.26% of all cancers. The most histologically, well-differentiated thyroid cancer is papillary thyroid carcinoma (PTC). Although PTC is regarded as an indolent tumor, a portion of the cancer cells metastasize to lymph nodes around the thyroid gland. Lymph node metastasis (LNM) is a critical risk factor for tumor recurrence in PTC, which strongly affects disease prognosis and the quality of life. Methods: This study aims to examine how differences in the level of the thyroid profile and other risk factors may influence LNM incidence in patients with PTC in Taiwan. We carried out a single-center retrospective study. These PTC patients were retrospectively reviewed by the Department of Endocrinology from 2016 to 2019. A total of 165 patients were included in our research. Results: The findings revealed a close relationship with the level of free thyroxine (FT4), the level of the thyroid-stimulating hormone (TSH), and lymph node metastases. The correlation in terms of FT4 (p = 0.005) and TSH (p = 0.417) with LNM was found as a result of the univariate regression analysis. In the multiple regression analysis, the findings revealed a close relationship between LNM, FT4 (p < 0.001), and TSH (p = 0.008). Conclusions: Although the predictability of the TSH should be examined further, the association between LNM and FT4 or TSH should not be ignored. The results could help guide decision-making and patient counseling, using the level of serum FT4 or the TSH as a possible predictive factor of the LNM in PTC. Full article
(This article belongs to the Section Endocrinology/Metabolism)
Show Figures

Figure 1

Figure 1
<p>Flow diagram of data extraction. PTC: papillary carcinoma; LNM: lymph node metastasis.</p>
Full article ">
15 pages, 1361 KiB  
Article
The Relationship between Proinflammatory Molecules and PD-L1 in Patients with Obesity Who Underwent Gastric Sleeve Surgery—A Pilot Study
by Ciprian Cucoreanu, Ximena Maria Muresan, Adrian-Bogdan Tigu, Madalina Nistor, Radu-Cristian Moldovan, Ioana-Ecaterina Pralea, Maria Iacobescu, Cristina-Adela Iuga, Catalin Constantinescu, George-Calin Dindelegan and Constatin Ciuce
Reports 2024, 7(3), 74; https://doi.org/10.3390/reports7030074 - 3 Sep 2024
Viewed by 1112
Abstract
In the last few decades, obesity played a pivotal role by having a high impact on global economic and health systems due to its associated diseases, with cardiovascular, respiratory, musculoskeletal, oncological, mental, and social implications. One of the most incriminated physiopathological mechanisms in [...] Read more.
In the last few decades, obesity played a pivotal role by having a high impact on global economic and health systems due to its associated diseases, with cardiovascular, respiratory, musculoskeletal, oncological, mental, and social implications. One of the most incriminated physiopathological mechanisms in obesity is chronic inflammation. The primary goal of this pilot study was to determine the molecular aspects of inflammation among patients with obesity compared to participants with a normal BMI (≤25 kg/m2), as well as within a smaller subset of obese individuals who have been evaluated three months following sleeve gastrectomy. The research employs conventional blood tests and plasma measurements of particular molecules, such as proinflammatory cytokines and proteins that play critical roles in immune and inflammatory regulation. The results revealed a promising kinetic effect after bariatric surgery on IL-18, MCP-1, and PD-L1 molecules. The proinflammatory makers IL-18 (p = 0.006) and MCP-1 (p = 0.035) were elevated in the obese group compared to the control, while the follow-up group displayed lower levels of these molecules. Commonly investigated in oncology related studies, PD-L1 was recently linked to adipose tissue gain and its associated inflammatory effect. Until now, there is no clinical evidence for the relationship between circulating PD-L1 and proinflammatory markers derived from low-grade inflammation of the adipose tissue. The circulating PD-L1 levels were significantly lowered in the obese group compared to the control (p = 0.049), and after sleeve gastrectomy, the PD-L1 level increased. The present study is the first investigating this type of crosstalk and its potential involvement in bariatric patient management. Full article
(This article belongs to the Section Endocrinology/Metabolism)
Show Figures

Figure 1

Figure 1
<p>Heatmap of median differences between obese and control cohorts. The color gradient from blue to red represents the difference between the median values of the obese group and the control group for each variable. The median value was calculated for the obese group using the same method as for the control group, and further subtracted the control group’s median from the obese group’s median for each variable. Blue indicates a smaller or negative difference, while red indicates a larger or positive difference. Variables with tiles that are more towards red have a larger positive difference (the obese group has higher values), while variables with tiles that are more towards blue have a smaller or negative difference (the obese group has lower values). HDL—high density lipoprotein; BMI—body mass index; PDL1—programmed death-ligand 1; MCP1—monocyte chemoattractant protein-1; IL-18—interleukin 18; CRP—C-reactive protein; ALT—alanine aminotransferase/alanine transaminase.</p>
Full article ">Figure 2
<p>Proinflammatory molecules and PD-L1 determinations—comparison between the three groups. Statistical evaluation was performed using GraphPad Prism (version 8) applying an unpaired two-tailed <span class="html-italic">t</span>-test with Welch’s correction, and the results are expressed as mean value ± SEM, * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 3
<p>Comparison of variables at baseline and follow-up, including all measured parameters. The upper panel displays box plots for each variable listed in the legend, which represents the interquartile range (IQR), which contains the middle 50% of the data. The line inside the box represents the median value. The lower panel shows bar plots for each variable. They represent the central tendency or the mean/median value for the baseline and follow-up measurements. Legend: 1. uric acid (mg/dL); 2. ALT (U/L); 3. albumin (g/dL); 4. AST (U/L); 5. total cholesterol (mg/dL); 6. creatinine (mg/dL); 7. CRP (mg/dL); 8. IL-18 (pg/mL); 9. IL-8 (pg/mL); 10. MCP-1 (pg/mL); 11. PD-L1 (pg/mL); 12. glucose (mg/dL); 13. HbA1c (%); 14. HDL (mg/dL); 15. hemoglobin (g/dL); 16. BMI (kg/m<sup>2</sup>); 17. LDL (mg/dL); 18. leukocytes (10<sup>9</sup>/L); 19. lymphocytes (10<sup>9</sup>/L); 20. monocytes (10<sup>9</sup>/L); 21. neutrophils (10<sup>9</sup>/L); 22. total proteins (g/dL); 23. iron (ug/dL); 24. triglycerides (mg/dL); 25. thrombocytes (10<sup>9</sup>/L); 26. urea (mg/dL).</p>
Full article ">Figure 4
<p>Correlation between hospital stay and PD-L1 and proinflammatory molecules.</p>
Full article ">
Back to TopTop